{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:06:54Z","timestamp":1792206414361,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL144552"],"award-info":[{"award-number":["R01HL144552"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R08HL163471-01"],"award-info":[{"award-number":["R08HL163471-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL157975-01A1"],"award-info":[{"award-number":["R01HL157975-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtha.2026.05.018","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:18:11Z","timestamp":1779725891000},"page":"3017-3029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human monoclonal and polyclonal anti-ADAMTS13 antibodies in immune thrombotic thrombocytopenic purpura: variable mechanisms of inhibition"],"prefix":"10.1016","volume":"24","author":[{"given":"Chan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9594-1852","authenticated-orcid":false,"given":"Konstantine","family":"Halkidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szumam","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-5295","authenticated-orcid":false,"given":"X. Long","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.05.018_bib1","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.018_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.018_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-2005-925468","article-title":"Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond","volume":"31","author":"Lian","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.018_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Chorba, Increasing mortality from thrombotic thrombocytopenic purpura in the United States--analysis of national mortality data, 1968-1991","volume":"50","author":"T\u00f6r\u00f6k","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.018_bib6","first-page":"2619","article-title":"Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura","author":"Gra\u00e7a","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.05.018_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jtha.2026.05.018_bib8","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood-2003-12-4165","article-title":"Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"103","author":"Klaus","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.018_bib9","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.05.018_bib10","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"Petri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2026.05.018_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2026.05.018_bib12","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1073\/pnas.1413282112","article-title":"Allosteric activation of ADAMTS13 by von Willebrand factor","volume":"111","author":"Muia","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.05.018_bib13","doi-asserted-by":"crossref","first-page":"29428","DOI":"10.1074\/jbc.M505513200","article-title":"The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor","volume":"280","author":"Ai","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.05.018_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH04-05-0301","article-title":"The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Luken","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib15","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/ATVBAHA.111.229609","article-title":"Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis","volume":"31","author":"Xiao","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.05.018_bib16","doi-asserted-by":"crossref","first-page":"30136","DOI":"10.1074\/jbc.M305331200","article-title":"Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13","volume":"278","author":"Zheng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2026.05.018_bib17","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","article-title":"Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura","volume":"102","author":"Scheiflinger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.018_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.05217.x","article-title":"von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura","volume":"127","author":"Peyvandi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.018_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jtha.2026.05.018_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2026.05.018_bib21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1538-7836.2006.02025.x","article-title":"Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo","volume":"4","author":"Shelat","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtha.2023.02.011","article-title":"Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura","volume":"21","author":"Underwood","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib23","first-page":"2993","article-title":"Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura","volume":"141","author":"Halkidis","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.018_bib24","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.05.018_bib25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.018_bib26","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"8","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib27","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"International Society on Thrombosis and Haemostasis. 2025 Focused Update of the 2020 ISTH Guidelines for Management of Thrombotic. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib28","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.1512561112","article-title":"High resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome","volume":"112","author":"Casina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.05.018_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-9861(83)90225-4","article-title":"The determination of thermodynamic allosteric parameters of an enzyme undergoing steady-state turnover","volume":"224","author":"Reinhart","year":"1983","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jtha.2026.05.018_bib30","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jth.15332","article-title":"A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura","volume":"19","author":"Halkidis","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102603","article-title":"Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura","volume":"8","author":"Halkidis","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtha.2024.11.020","article-title":"A novel automated chemiluminescent enzyme immunoassay for ADAMTS-13 activity enables accompanying measurements of the inhibitory autoantibodies","volume":"23","author":"Kubo","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fmicb.2020.01927","article-title":"Solubility, stability, and avidity of recombinant antibody fragments expressed in microorganisms","volume":"11","author":"Kang","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jtha.2026.05.018_bib34","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.14602","article-title":"Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor","volume":"17","author":"Rottensteiner","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1538-7836.2009.03568.x","article-title":"IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura","volume":"7","author":"Ferrari","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jtha.2023.12.028","article-title":"ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura","volume":"22","author":"Underwood","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3324\/haematol.2010.036327","article-title":"Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain","volume":"96","author":"Pos","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.05.018_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3324\/haematol.2013.094151","article-title":"Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura","volume":"99","author":"Ferrari","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.05.018_bib39","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3389\/fimmu.2018.01646","article-title":"Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic purpura","volume":"9","author":"Sinkovits","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.05.018_bib40","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1538-7836.2012.04808.x","article-title":"ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura","volume":"10","author":"Bettoni","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.05.018_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4161\/mabs.4.1.18347","article-title":"Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function","volume":"4","author":"Liu","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.jtha.2026.05.018_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ab.2006.06.022","article-title":"Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays","volume":"358","author":"Zhang","year":"2006","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2026.05.018_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.018_bib45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2005.01767.x","article-title":"FRETS-VWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura","volume":"4","author":"Groot","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib47","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/bloodadvances.2019000939","article-title":"Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura","volume":"3","author":"Sui","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.018_bib48","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jtha.2024.02.003","article-title":"Mechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura","volume":"22","author":"Zheng","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ab.2013.07.022","article-title":"Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system","volume":"442","author":"Chen","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2026.05.018_bib50","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/bloodadvances.2019001375","article-title":"Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function","volume":"4","author":"Schelpe","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.018_bib51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2026.05.018_bib52","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1021\/ja203638y","article-title":"Mechanism of immunoglobulin G4 Fab-arm exchange","volume":"133","author":"Rispens","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtha.2026.05.018_bib53","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jtha.2026.05.018_bib54","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2006.01833.x","article-title":"ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences","volume":"4","author":"Feys","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.018_bib55","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1641151","article-title":"Evaluation of the fully automated HemosIL Acustar ADAMTS13 activity assay","volume":"118","author":"Favresse","year":"2018","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:21:27Z","timestamp":1785885687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1538783626003417"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.018","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human monoclonal and polyclonal anti-ADAMTS13 antibodies in immune thrombotic thrombocytopenic purpura: variable mechanisms of inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}